The U.S. Food and Drug Administration is proposing to amend postmarket safety reporting regulations for three of its centers to require that manufacturers and other facilities subject to current reporting requirements submit their reports in an electronic format. The agency issued two proposed rules today-one that applies to electronic medical device adverse event reporting and one that applies to electronic drug and biologic product adverse experience reporting.